GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art - Nauck, Michael A.; Quast, Daniel R.; Wefers, Jakob; Meier, Juris J. (Molecular metabolism (Germany), 2021)
Keywords: Albiglutide; Body weight; Cardiovascular disease; Dulaglutide; Exenatide; Glucagon-like peptide-1 receptor agonists; Liraglutide; Lixisenatide; Review; Semaglutide; Type 2 diabetes; Type 2 diabetes; Dulaglutide; Body weight; Semaglutide; Cardiovascular disease; Glucagon-like peptide-1 receptor agonists; Albiglutide; Exenatide; Lixisenatide; Liraglutide